Loading…
Boston Scientific Corporation is projected to rise to $49.62 by 2027, a +11% move from its current price of $44.77. BSX is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/12/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $44.04 | $44.78 | $45.53 | +0.02% |
| Jul 14 | $43.74 | $44.78 | $45.85 | +0.03% |
| Jul 15 | $43.52 | $44.79 | $46.10 | +0.05% |
| Jul 16 | $43.33 | $44.80 | $46.31 | +0.06% |
| Jul 17 | $43.17 | $44.80 | $46.50 | +0.08% |
| Jul 18 | $43.03 | $44.81 | $46.67 | +0.09% |
| Jul 19 | $42.89 | $44.82 | $46.83 | +0.11% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $42.89 | $44.82 | $46.83 | +0.11% |
| Week 2 | $42.16 | $44.87 | $47.74 | +0.21% |
| Week 3 | $41.62 | $44.91 | $48.46 | +0.32% |
| Week 4 | $41.18 | $44.96 | $49.09 | +0.43% |
| Week 5 | $40.80 | $45.01 | $49.65 | +0.53% |
| Week 6 | $40.46 | $45.06 | $50.17 | +0.64% |
| Week 7 | $40.16 | $45.10 | $50.66 | +0.75% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. The company operates in two segments, MedSurg and Cardiovascular, and offers devices to diagnose and treat a range of gastrointestinal conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, SpyGlass, single-use scopes used for diagnostic and therapeutic procedures in the pancreaticobiliary system, in endoscopic retrograde cholangiopancreatography procedures, and single-use duodenoscopes, as well as endoluminal surgery and infection prevention products; devices to treat urological conditions, including ureteral stents, catheters, baskets, guidewires, urinary and bowel dysfunction, sheaths, balloons, single-use digital flexible ureteroscopes, holmium laser systems, penile implants, artificial urinary sphincter, laser system, and hydrogel systems; and devices to treat neurological movement disorders and manage chronic pain, such as spinal cord stimulator systems, radiofrequency ablation, and intraosseous nerve ablation and deep brain stimulation systems. The company also provides technologies for diagnosing and treating a range of diseases and abnormalities of the heart; WATCHMAN FLX, a left atrial appendage closure (LAAC) device; and implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities, such as cardioverter and cardiac resynchronization therapy defibrillators, MRI S-ICD systems, cardiac resynchronization therapy pacemakers, remote patient management systems, insertable cardiac monitor systems, and remote cardiac monitoring systems.
In addition, it offers diagnosis and treatment of rate and rhythm disorders of the heart; peripheral arterial and venous diseases; and products to diagnose and treat forms of cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.
Boston Scientific Corporation (BSX) is a healthcare company that develops, manufactures, and markets medical devices for interventional medical specialties worldwide, with two segments: MedSurg and Cardiovascular. The stock is currently trading with a market cap of $64.63B and a price of $43.48. It ranks 249 by market position.
A major floor 12.7% below — a decisive break under it would weaken the trend.
The nearest floor, 4.7% below — buyers have tended to step in here.
The nearest ceiling, 9.7% above — a clean break opens room to run.
A major ceiling 65.0% above — clearing it would confirm fresh momentum.
Key BSX support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of BSX market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $44.89 | Sell | $44.77 | Sell |
| MA 10 | $44.31 | Buy | $44.75 | Buy |
| MA 20 | $44.98 | Sell | $45.61 | Sell |
| MA 50 | $49.87 | Sell | $50.35 | Sell |
| MA 100 | $58.98 | Sell | $58.91 | Sell |
| MA 200 | $77.10 | Sell | $70.66 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 40.48 | Neutral |
| Stoch RSI (14) | 89.96 | Sell |
| CCI (20) | -15.34 | Neutral |
| Williams %R (14) | -28.42 | Info |
| MACD (12,26,9) | 0.48 | Buy |
| ROC (12) | -1.82 | Sell |
| Bollinger %B (20,2) | 0.46 | Neutral |
| Stochastic %K (14) | 71.58 | Neutral |
| TRIX (15) | -0.61 | Sell |
| Awesome (5,34) | -2.37 | Sell |
| Ultimate (7,14,28) | 60.76 | Neutral |
| Momentum (10) | 0.57 | Buy |
| Aroon Osc (25) | -56.00 | Sell |
| Hull MA (9) | 45.27 | Sell |
| ADX (14) | 31.92 | Sell |
| ATR (14) | 0.72 | Info |
The 30-day technical picture is NEUTRAL. The RSI(14) is 30, reflecting modest near-term momentum.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $42.68 | $44.77 | $54.80 | 0% | Neutral | |
| $40.64 | $49.62 | $63.34 | +11% | Neutral | |
| $45.86 | $57.05 | $74.80 | +27% | Bullish | |
| $48.65 | $61.45 | $82.28 | +37% | Bullish | |
| $49.31 | $63.12 | $86.04 | +41% | Bullish | |
| $48.20 | $62.46 | $86.49 | +40% | Bullish | |
| $51.28 | $67.20 | $94.37 | +50% | Bullish | |
| $53.80 | $71.25 | $101.35 | +59% | Bullish | |
| $58.11 | $77.72 | $111.88 | +74% | Bullish | |
| $66.17 | $89.34 | $130.04 | +100% | Bullish | |
| $80.50 | $113.35 | $172.91 | +153% | Bullish | |
| $122.44 | $184.91 | $302.34 | +313% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $42.68 | $44.77 | $52.86 | +0.00% |
| August 2026 | $38.92 | $45.55 | $54.47 | +1.75% |
| September 2026 | $38.60 | $45.39 | $54.71 | -0.35% |
| October 2026 | $37.28 | $44.03 | $53.41 | -3.00% |
| November 2026 | $37.06 | $43.92 | $53.58 | -0.24% |
| December 2026 | $37.59 | $44.69 | $54.80 | +1.75% |
Click any year to see its month-by-month BSX forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The BSX price prediction for 2026 points to an average of $44.77 (low $42.68, high $54.80) — a potential gain of 0% on today's $44.77. Price action looks broadly range-bound.
In 2027, BSX is projected to trade between $40.64 and $63.34, averaging $49.62 — a potential gain of +11% from today's $44.77. That is up +11% on the projected 2026 average. A consolidation phase looks the most probable path here.
Boston Scientific Corporation's 2028 outlook centres on $57.05, within a $45.86 to $74.80 range. That is up +15% on the projected 2027 average. That marks a +27% change versus current levels. Momentum favours further upside here.
By 2029, BSX could reach as high as $82.28, with a base case around $61.45 and support toward $48.65 — roughly +37% from $44.77. Buyers look set to stay in control over this stretch.
Expect BSX to range from $49.31 to $86.04 through 2030. The $63.12 average target implies a +41% move from current prices. That is up +3% on the projected 2029 average. Momentum favours further upside here.
The BSX price prediction for 2031 points to an average of $62.46 (low $48.20, high $86.49) — a potential gain of +40% on today's $44.77. Buyers look set to stay in control over this stretch.
In 2032, BSX is projected to trade between $51.28 and $94.37, averaging $67.20 — a potential gain of +50% from today's $44.77. That is up +8% on the projected 2031 average. Momentum favours further upside here.
Boston Scientific Corporation's 2033 outlook centres on $71.25, within a $53.80 to $101.35 range. That is up +6% on the projected 2032 average. That marks a +59% change versus current levels. Buyers look set to stay in control over this stretch.
By 2034, BSX could reach as high as $111.88, with a base case around $77.72 and support toward $58.11 — roughly +74% from $44.77. Momentum favours further upside here.
Expect BSX to range from $66.17 to $130.04 through 2035. The $89.34 average target implies a +100% move from current prices. That is up +15% on the projected 2034 average. Buyers look set to stay in control over this stretch.
The BSX price prediction for 2040 points to an average of $113.35 (low $80.50, high $172.91) — a potential gain of +153% on today's $44.77. Momentum favours further upside here.
In 2050, BSX is projected to trade between $122.44 and $302.34, averaging $184.91 — a potential gain of +313% from today's $44.77. That is up +63% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in BSX today (≈ 22.336386 BSX) could be worth
$4,130.14
+$3,130.14 (+313%) by 2050 · US Dollar
Based on the average projected BSX price of $184.91 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in BSXwould be worth at today's price.
$1,000 invested in BSX on Jul 10, 2025 (≈ 9.628346 BSX) would be worth
$431.06
-$568.94 (-56.9%) today · 0.43× · US Dollar
Based on a BSX entry price of $103.86 vs. today's $44.77.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $45.14 | $991.8 | -0.8% |
| 1 month ago | $48.34 | $926.15 | -7.4% |
| 3 months ago | $61.79 | $724.55 | -27.5% |
| 6 months ago | $95.72 | $467.72 | -53.2% |
| 1 year ago | $103.86 | $431.06 | -56.9% |
| All time (5.0y) ago | $43.06 | $1,039.71 | +4.0% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our BSX forecast.
Our base-case forecast reaches $90.00 around 2040.
Implied market cap at $90.00: $133.77B
Longer-term forecasts show a bullish trajectory across multiple years. By 2030 the average price is $60.07 with a low of $46.90 and a high of $81.93, and a forecasted ROI of 38.1. By 2040 the average price is $108.03 with a low of $76.70 and a high of $164.82, and a forecasted ROI of 148.4.
By 2050 the average price is $173.44 with a low of $114.82 and a high of $283.65, and a forecasted ROI of 298.9. The outlook remains bullish across these years, though these figures are estimates and not guarantees.
Tap a question to reveal the answer.
The 2030 forecast shows an average price of $60.07, a minimum of $46.90, and a maximum of $81.93, with an ROI of 38.1 and a bullish sentiment.
The forecasts indicate a bullish trajectory in the long term, with average prices rising to $60.07 by 2030 and to $173.44 by 2050, and ROIs of 38.1 by 2030, 148.4 by 2040, and 298.9 by 2050.
Yes. The 2030 forecast lists a maximum of $81.93, with an average of $60.07.
The current price is $43.48 and the market cap is $64.63B; the stock ranks 249 by market position.
The 30-day range is $38.89 to $48.62. The sentiment is NEUTRAL, RSI(14) is 30, SMA(50) is $52.68, SMA(200) is $79.31, with support at $43.48 and resistance at $57.78.
Boston Scientific Corporation Community Discussion
0Share your Boston Scientific Corporation price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.